Thyroid hormone resistance

Area of Science:

• Endocrinology
• Genetics
• Molecular Biology

Background:

• Resistance to thyroid hormone (RTH) is a rare inherited condition characterized by diminished end-organ sensitivity to thyroid hormones.
• Patients present with elevated thyroid hormone levels (free thyroxine and free triiodothyronine) and normal or slightly elevated thyroid-stimulating hormone.
• Clinical manifestations include goiter, but typically lack symptoms of thyroid hormone excess.

Purpose of the Study:

• To summarize the key features, classification, genetic basis, and diagnostic challenges of Resistance to Thyroid Hormone.
• To highlight the importance of accurate diagnosis for appropriate patient management and genetic counseling.

Main Methods:

• Review of clinical and genetic data from patients with Resistance to Thyroid Hormone.
• Analysis of identified mutations in the thyroid hormone receptor beta (TRbeta) gene.
• Discussion of differential diagnoses and implications of misdiagnosis.

Main Results:

• 122 distinct mutations in the TRbeta gene have been identified in approximately 300 families.
• Most RTH cases result from minor DNA alterations, with one family showing complete TRbeta gene deletion.
• Misdiagnosis of RTH as primary thyrotoxicosis leads to inappropriate treatment in a significant proportion of patients.

Conclusions:

• Accurate differentiation of RTH from other thyroid conditions is essential to prevent incorrect treatment.
• No specific treatment exists for RTH, but diagnosis facilitates genetic counseling.
• Understanding the genetic basis and clinical spectrum of RTH is vital for patient care.